skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Positive modulator of bone morphogenic protein-2

Abstract

Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.

Inventors:
; ; ;
Publication Date:
Research Org.:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1361549
Patent Number(s):
9,670,258
Application Number:
15/240,977
Assignee:
Brookhaven Science Associates, LLC LBNL
DOE Contract Number:
ACO2-98CH1086
Resource Type:
Patent
Resource Relation:
Patent File Date: 2016 Aug 18
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Zamora, Paul O., Pena, Louis A., Lin, Xinhua, and Kazuyuki, Takahashi. Positive modulator of bone morphogenic protein-2. United States: N. p., 2017. Web.
Zamora, Paul O., Pena, Louis A., Lin, Xinhua, & Kazuyuki, Takahashi. Positive modulator of bone morphogenic protein-2. United States.
Zamora, Paul O., Pena, Louis A., Lin, Xinhua, and Kazuyuki, Takahashi. Tue . "Positive modulator of bone morphogenic protein-2". United States. doi:. https://www.osti.gov/servlets/purl/1361549.
@article{osti_1361549,
title = {Positive modulator of bone morphogenic protein-2},
author = {Zamora, Paul O. and Pena, Louis A. and Lin, Xinhua and Kazuyuki, Takahashi},
abstractNote = {Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Jun 06 00:00:00 EDT 2017},
month = {Tue Jun 06 00:00:00 EDT 2017}
}

Patent:

Save / Share: